MAVS antibody (AA 461-510)
Quick Overview for MAVS antibody (AA 461-510) (ABIN7229586)
Target
See all MAVS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 461-510
-
Purpose
- Rabbit Anti-MAVS Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of MAVS protein
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human MAVS protein at AA range: 461-510
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Alternative Name
- MAVS
-
Background
- Mitochondrial antiviral-signaling protein, MAVS, CARD adapter inducing interferon beta, Interferon beta promoter stimulator protein 1, IPS-1, Putative NF-kappa-B-activating protein 031N, Virus-induced-signaling adapter, VISAMAVS encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral immunity. Multiple transcript variants encoding different isoforms have been found for MAVS.
-
Molecular Weight
- 59kD
-
Gene ID
- 57506
-
UniProt
- Q7Z434
-
Pathways
- Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
Target
-